Ambarella Inc

After holding above the 200-day SMA and demonstrating resilience in a Stage 2 advancing uptrend, AMBA’s medium-term bias remains bullish. Short-term momentum is unfavorable as price trades below the 9 and 20 EMAs and under the 50-day SMA, so execution is deferred. Look for pullbacks into the 50-day SMA or the 200-day SMA support zones for potential entries. A decisive reclaim and acceptance above the 9/20 EMAs and 50-day SMA would pivot timing toward immediate buys.

• ↑Q1’27 revenue $100.4M, +16.9% YoY
• ↑$800M long-term agreement with Hanwha enhances revenue visibility
• ↓Negative profitability score and weak earnings yield signal cash-burn risk